Postmarketing Safety of Biosimilars: Current Status, Challenges, and Opportunities in the Spontaneous Reporting System

Therapeutic Innovation & Regulatory Science - Tập 54 Số 3 - Trang 667-680 - 2020
Amarendra Pratap Singh1, Mani Kalaivani1, Sushma Srivastava2, Ramesh K. Goyal3, Suresh Gupta3
1Biologics Section, Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare (Government of India), Ghaziabad, India
2Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare (Government of India), Ghaziabad, India
3Delhi Pharmaceutical Sciences and Research University, New Delhi, India

Tóm tắt

Từ khóa


Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Therapeutic Innovation & Regulatory Science

Tập 54 Số 3

667-680

Thông tin tác giả